Longevity Science Left the Clinic. Lifespanning Put It in a Shopping Cart.

The pitch behind Lifespanning is almost boring, and that is the point. For most of the last decade, the best longevity science lived inside private clinics that charged five figures a year. You could read about it in a magazine, but you could not easily buy it, and you certainly could not trust the version sold to you on the open internet, where every powder promises to reverse aging and almost none show the studies. Lifespanning's answer is not another miracle molecule. It is a filter.

The company - legally Lifespanning Media Corp, headquartered on Brickell Avenue in Miami - grew out of Biohackers Magazine, a publication that has been covering cold plunges, peptides and epigenetic testing since 2019. In October 2023 the founders folded that magazine into a broader brand and set out to do something publishers rarely manage: turn a large, loyal audience into a business that sells more than ads. The result, launched publicly in June 2025, is a certified longevity marketplace of more than 1,000 tests, supplements and devices - each one screened before it ever reaches a product page.

What the company actually does

01A referee, not another brand

Most companies in this space pick a lane. They either publish content or they sell a house-label supplement. Lifespanning does both, but the interesting move is the posture in between. Rather than manufacturing its own pills and marking them up, it positions itself as the referee - a neutral shelf that stocks products from across the industry and grades each one. Every item in the marketplace is run against a 72-point vetting rubric that weighs the strength of the evidence and the quality of manufacturing. Products that pass carry an evidence badge and dosage guidance printed right on the page. A panel of more than 20 longevity scientists and clinicians reviews the catalog every quarter, so the shelf is meant to change as the research does.

The problem it is solving

02An industry with a trust problem

The longevity market is enormous and getting bigger - roughly $63.6 billion in 2023, and projected to pass $120 billion by 2030, according to figures the company cites. Growth on that scale attracts a lot of noise. Search for any popular compound and you will find a hundred sellers, wildly different prices, and label language ("clinically studied," "physician formulated") that sounds precise and means almost nothing. For a buyer, the hard part is not access anymore. It is knowing which of the hundred bottles is worth the money.

Lifespanning's bet is that the scarce resource in a crowded market is trust, and that a graded catalog is a product in its own right. Instead of asking shoppers to become part-time researchers, it does the reading and shows its work. Products are organized by biology rather than brand, sorted into longevity pillars so a buyer can start from a goal - sleep, metabolism, recovery - rather than a marketing category.

The reasoning that got them here is worth spelling out, because it doubles as the origin story. After roughly two decades on the frontline of biohacking research, the founders kept running into the same wall: the most credible longevity science stayed locked inside exclusive clinics, priced for a narrow clientele, while the mass-market version online was a free-for-all. The fix they settled on was not to open a clinic of their own. It was to recruit the experts, put thousands of products through hard scientific scrutiny, and fight suppliers on price - then hand the result to anyone with a browser.

Products and services

03A magazine that became a store

The marketplace is the centerpiece, but it sits on top of a stack the company built first. Lifespanning Magazine, the descendant of Biohackers Magazine, still runs with a reported 300,000-plus monthly readers and a back catalog of interviews with the field's best-known names, from Bryan Johnson to Dave Asprey to Ben Greenfield to Jim Kwik. A podcast translates dense papers into something you can follow on a walk. There are live events and keynotes at longevity conferences, an academy and coaching arm that builds personalized protocols from blood tests and biological-age assessments, and Lifespan Certified, a certification program created by Biohackers Magazine founder Dallas McClain.

The newest limb is LifespanningRx, a telehealth service that connects users with licensed U.S. providers and compounding pharmacies for prescriptions the off-the-shelf catalog cannot cover. Put together, it is an unusually complete funnel: attention at the top, commerce in the middle, and clinical services at the base.

Who buys it

04From hardcore biohackers to nervous first-timers

The audience splits in two. On one end are the committed biohackers who already track their own bloodwork and want a trustworthy place to buy without wading through knockoffs. On the other are ordinary health-conscious adults - people who have heard the longevity conversation, feel a little intimidated by it, and want a guided entry point that will not sell them junk. Lifespanning's community is cited at more than 5 million across its channels, with fulfillment running two to four days across North America and Europe, plus free U.S. delivery and a best-price guarantee designed to remove the last excuse not to try.

How it is different

05The edge is a rubric, not a molecule

Plenty of companies want your longevity dollars. Testing and diagnostics players like Function Health, InsideTracker and Levels sell you data about your body. Single-brand supplement makers like Thorne, Novos and Lifeforce sell you their formula. Bryan Johnson's Blueprint sells a protocol built around one man's very expensive routine. Human Longevity Inc. and concierge clinics sell the premium, in-person version of all of it.

Lifespanning's difference is that it does not need you to believe in any single product. Its edge is the grading system and the media brand that lends it credibility. If the rubric is honest and the panel is real, the company can stay useful no matter which supplement is in fashion this year, because its job is to sort the field rather than win it. That is a genuinely different bet from "trust our pill," and it is the reason a five-person team can credibly stand in front of a $120 billion market.

The business, and the people

06Small team, media-first leverage

Lifespanning is led by founder and CEO Jean Fallacara, a bioengineer and neuroscientist who writes under the handle @cyborggainz, authored a book on training the nervous system, and was named among the Top 30 Most Disruptive Entrepreneurs in 2023. He built the company - originally CyborgMedia LLC - alongside co-founders including Yannick Namia and Jonathan Singer. The headcount is small, in the range of five, which is exactly what makes the model interesting. The heavy lifting is done by content and a review panel rather than a large sales operation, so the audience it spent years building does the work of customer acquisition for free.

There is a fair question buried in all of this, and it is worth stating plainly: the whole thing only works if the grading stays independent of what sells. A marketplace that also runs the rubric has an obvious incentive to grade generously. Lifespanning's public answer is the 72-point system, the evidence badges and the quarterly expert review - transparency as the check. Whether that holds up as the catalog grows is the story worth watching, and it is the one detail that separates a trustworthy shelf from a very well-designed store.

What a reader can take from Lifespanning is not really about supplements. It is a template: earn an audience with useful content, then sell that audience the thing they were going to buy anyway - but vetted, sorted and priced fairly. It is a simple idea in a market that has made simplicity hard to find.